Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 73.86
+2.86 (4.03%)
Oct 15, 2026, 9:38 AM EST
Bright Minds Biosciences Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Bright Minds Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $136.50. The average 1-year stock price forecast is 84.81% higher than the current stock price, while the lowest is $126.00 (+70.59%) and the highest is $147.00 (+99.03%).
Price Target: $136.50 (+84.81%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Bright Minds Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy Initiates $213.22 | Buy | Initiates | $213.22 | +188.68% | Oct 15, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Initiates $207.53 | Buy | Initiates | $207.53 | +180.98% | Oct 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $312.72 | Buy | Maintains | $312.72 | +323.40% | Oct 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $206.11 | Buy | Maintains | $206.11 | +179.06% | Sep 22, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 17, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
30.25M
EPS This Year
-3.67
from -1.78
EPS Next Year
-8.20
from -3.67
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.